Association of low skeletal muscle mass with advanced liver fibrosis in patients with non‐alcoholic fatty liver disease

2019 ◽  
Vol 34 (9) ◽  
pp. 1633-1640 ◽  
Author(s):  
Min Kyu Kang ◽  
Jung Gil Park ◽  
Heon Ju Lee ◽  
Min Cheol Kim
Biology ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 122
Author(s):  
Jun-Hyuk Lee ◽  
Hye-Sun Lee ◽  
Byoung-Kwon Lee ◽  
Yu-Jin Kwon ◽  
Ji-Won Lee

Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whether NAFLD is a risk factor for the development of sarcopenia is not clear. We investigated relationships between NAFLD and low skeletal muscle mass index (LSMI) using three different datasets. Participants were classified into LSMI and normal groups. LSMI was defined as a body mass index (BMI)-adjusted appendicular skeletal muscle mass <0.789 in men and <0.512 in women or as the sex-specific lowest quintile of BMI-adjusted total skeletal muscle mass. NAFLD was determined according to NAFLD liver fat score or abdominal ultrasonography. The NAFLD groups showed a higher hazard ratios (HRs) with 95% confidence intervals (CIs) for LSMI than the normal groups (HRs = 1.21, 95% CIs = 1.05–1.40). The LSMI groups also showed a higher HRs with 95% CIs for NAFLD than normal groups (HRs = 1.56, 95% CIs = 1.38–1.78). Participants with NAFLD had consistently less skeletal muscle mass over 12 years of follow-up. In conclusion, LSMI and NAFLD showed a relationship. Maintaining muscle mass should be emphasized in the management of NAFLD.


2018 ◽  
Vol 154 (6) ◽  
pp. S-1176
Author(s):  
Devika Kapuria ◽  
Firas Ghomraoui ◽  
Phil Brown ◽  
Gil S. Ben-Yakov ◽  
David Kleiner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document